Hypericin: A promising fluorescence marker for differentiating between glioblastoma and neurons in vitro

International Journal of Oncology

Volumn 27, Issue 6, 2005, Pages 1543-1549

  Ritz, Rainer ^a   Müller, Martin ^a   Weller, Michael ^b   Dietz, Klaus ^b   Kuci, Selim ^b   Roser, Florian ^a   Tatagiba, Marcos ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Fluorescence; Glioblastoma; Hypericin; Neurons; Photodynamic therapy

Indexed keywords

DRUG DERIVATIVE; HYPERICIN; PERYLENE;

ANIMAL; ARTICLE; ASTROCYTE; CELL CULTURE; CHEMISTRY; COMPARATIVE STUDY; CYTOLOGY; FLUORESCENCE; FLUORESCENCE MICROSCOPY; GLIOBLASTOMA; HUMAN; METABOLISM; METHODOLOGY; NERVE CELL; NEWBORN; PATHOLOGY; RAT; TIME; TUMOR CELL LINE;

ANIMALS; ANIMALS, NEWBORN; ASTROCYTES; CELL LINE, TUMOR; CELLS, CULTURED; FLUORESCENCE; GLIOBLASTOMA; HUMANS; MICROSCOPY, FLUORESCENCE; NEURONS; PERYLENE; RATS; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 33644826750     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Duran N and Song PS: Hypericin and its photodynamic action. Photochem Photobiol 43: 677-680, 1986.
2. Lavie G, Mazur Y, Lavie D and Meruelo D: The chemical and biological properties of hypericin - a compound with a broad spectrum of biological activities. Med Res Rev 15: 111-119, 1995.
3. Takahashi I, Nakanishi S, Kobayashi E, Nakano H, Suzuki K and Tanaoki T: Hypericin and pseudohypericin specifically inhibit protein kinase C: possible relation to their antiretroviral activity. Biochem Biophys Res Commun 165: 1207-1212,1989.
4. Couldwell WT, Uhm JH, Antel JP and Yong VW: Enhanced protein kinase C activity correlates with the growth rate of malignant gliomas in vitro. Neurosurgery 29: 880-887,1991.
5. Pace N: The etiology of hypericism', a photosensitivity produced by St. Johns wort. Am J Physiol 136: 650-656, 1942.
6. Weller M, Trepel M, Grimmel C, Schabet M, Bremen D, Krajeweski S and Reed JC: Hypericin-induced apoptosis of human malignant glioma cells is light-dependent, independent of bcl-2 expression, and does not require wild-type p53. Neurol Res 19: 459-470,1997.
7. Miccoli L, Beurdeley-Thomas A, de Pinieux G, Sureau F, Oudard S, Dutrillaux B and Poupon MM: Light-induced photoactivation of hypericin affects the energy metabolism of human glioma cells by inhibiting hexokinase bound to mitochondria. Cancer Res 58: 5777-5786, 1998.
8. Lavie G, Kaplinsky C, Toren A, Aizman I, Meruelo D, Mazur Y and Mandel M: A photodynamic pathway to apoptosis and necrosis induced by dimethyl tetrahydroxyhelianthrone and hypericin in leukaemic cells possible relevance to photodynamic therapy. Br J Cancer 9: 423-432,1999.
9. Zupko I, Kamuhabwa AR, D'Hallewin MA, Baert L and de Witte PAM: In vivo photodynamic activity of hypericin in transitional cell carcinoma bladder tumors. Int J Oncol 18: 1099-1105,2001.
10. Couladis M, Badisa RB, Baziou P, Chaudhuri SK, Pilarinou E, Verykokidou E and Harvala C: Antioxidant and cytotoxic activities of Hypericum sp. on brine shrimps and human cancer cell lines. Phytother Res 16: 719-722, 2002.
11. Liu CD, Kwan D, Sayton RE and McFadden DW: Hypericin and photodynamic therapy decreases human pancreatic cancer in vitro and in vivo. J Surg Res 93: 137-143, 2000.
12. Duffner F, Ritz R, Freudenstein D, Weller M, Dietz K and Wessels J: Specific intensity imaging for glioblastoma and neural cell cultures with 5-aminolevulinic acid-derived protoporphyrin IX. J Neurooncol 71: 107-111,2005.
13. Ali SM and Olivo M: Bio-distribution and subcellular localization of hypericin and its role in PDT-induced apoptosis in cancer cells. Int J Oncol 21: 531-540, 2002.
14. Du H-Y, Olivo M, Tan BK-H and Bay B-H: Hypericinmediated photodynamic therapy induces lipid peroxidation and necrosis in nasopharyngeal cancer: Int J Oncol 23: 1401-1405, 2003.
15. Piette J, Volanti C, Vantieghem A, Matroule J-Y, Habraken Y and Agostinis P: Cell death and growth arrest in response to photodynamic therapy with membrane-bound photosensitizers. Biochem Pharmacol 66: 1651-1659, 2003.
16. Okpanyi SN, Lidzba H, Scholl BC and Miltenburger HG: Genotoxizität eines standardisierten Hypericum-Extraktes. Arzneimittelforschung 40: 851-855,1990.
17. Diwu Z and Lown JW: Phototherapeutic potential of alternative photosensitizers to phorphyrins. Pharmacol Ther 63: 1-35,1994.
18. English DS, Doyle RT, Petrich JW and Haydon PG: Subcellular distributions and excited state processes of hypericin in neurons. Photochem Photobiol 69:301-305,1999.
19. Miskovsky P, Sureau F, Chinsky L and Turpin P-Y: Subcellular distribution of hypericin in human cancer cells. Photochem Photobiol 62: 546-549,1995.
20. Uzdensky AB, Ma LW, Iani V, Hjortland GO, Stehen HB and Moan J: Intracellular localisation of hypericin in human glioblastoma and carcinoma cell lines. Lasers Med Sci 16: 276-283, 2001.
21. Uzdensky AB, Bragin DE, Kolosov MS, Kubin A, Loew HG and Moan J: Photodynamic effect of hypericin and a watersoluble derivative on isolated crayfish neuron and surrounding glial cells. Photochem Photobiol B 72: 27-33, 2003.
22. Kamuhabwa AR, Agostinis PM, D'Hallewin M-A, Baert L and de Witte PAM: Cellular photodestruction induced by hypericin in AY-27 rat bladder carcinoma cells: Photochem Photobiol 74: 126-132,2001.
23. Zhang W, Law RE, Hinton DR and Couldwell WT: Inhibition of human malignant glioma cell motility and invasion in vitro by hypericin, a potent protein kinase C inhibitor. Cancer Lett 120:31-38,1997.
24. Couldwell WT, Gopalakrishna R, Hinton DR, He S, Weiss MH, Law RE and Apuzzo MLJ: Hypericin: a potential antiglioma therapy. Neurosurgery 35: 705-710, 1994.
25. Ali SM and Olivo M: Mechanisms of action of phenanthro-perylenequinones in photodynamic therapy (Review). Int J Oncol 22: 1181-1191, 2003.
26. Hostanska K, Reichling J, Bommer S, Weber M and Sailer R: Aqueous ethanolic extract of St. John's wort (Hypericum perforatum L.) induces growth inhibition and apoptosis in human malignant cells in vitro. Pharmazie 57: 323-331, 2002.
27. D'Hallewin MA, de Witte PA, Waelkens E, Merlevede W and Baert L: Fluorescence detection of flat bladder carcinoma in situ after intravesical instillation of hypericin. J Urol 164: 349-351, 2000.
28. Kamuhabwa AAR, Cosserat-Gerardin I, Didelon J, Notter D, Guillemin F, Roskams T, D'Hallewin MA, Baert L and de Witte PAM: Biodistribution of hypericin in orthotopic transitional cell carcinoma bladder tumors: implication for whole bladder wall photodynamic therapy. Int J Cancer 97: 253-260, 2002.
29. Chen B, Xu Y, Roskams T, Delaey E, Agostinis P, Vandenheede JR and de Witte P: Efficacy of antitumoral photodynamic therapy with hypericin: relationship between biodistribution and photodynamic effects in the RIF-1 mouse tumor model. Int J Cancer 93: 275-282, 2001.
30. Luksiene Z and de Witte PAM: Hypericin as novel and promising photodynamic therapy tool: studies on intracellular accumulation capacity and growth inhibition efficiency. Medicina (Kaunas) 39: 677-682, 2003.